Biogen Tops Second-Quarter Estimates With Alzheimer's Drug Not Yet ProfitableInvestors Business Daily • 07/25/23
Biogen tops earnings estimates and says it will shift resources to higher value areasMarket Watch • 07/25/23
All Eyes On Biogen's Alzheimer's Drug, A Big Potential Payday, Ahead Of EarningsInvestors Business Daily • 07/24/23
Earnings Preview: Biogen Inc. (BIIB) Q2 Earnings Expected to DeclineZacks Investment Research • 07/18/23
Why Biogen Inc. (BIIB) is Poised to Beat Earnings Estimates AgainZacks Investment Research • 07/12/23
Leqembi approval offers renewed hope for novel Alzheimer's disease treatmentsProactive Investors • 07/10/23